Australia markets open in 6 hours 53 minutes

Addex Therapeutics Ltd (ADXN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.85+0.44 (+4.68%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
3,553
3,613
2,763
6,044
0
Cost of revenue
-
-
230.097
144.169
29.764
Gross profit
-
-
2,533
5,900
-29.764
Operating expenses
Research development
9,569
10,373
12,454
2,368
841.308
Selling general and administrative
4,796
5,146
4,265
4,717
2,196
Total operating expenses
14,671
15,856
17,367
7,468
3,235
Operating income or loss
-11,118
-12,243
-14,604
-1,425
-3,235
Interest expense
35.073
69.502
128.518
220.173
45.35
Total other income/expenses net
-
-581.128
-84.803
-
-
Income before tax
-11,192
-12,859
-14,781
-1,645
-3,280
Income tax expense
0
0
0
0
-
Income from continuing operations
-11,192
-12,859
-14,781
-1,645
-3,280
Net income
-11,192
-12,859
-14,781
-1,645
-3,280
Net income available to common shareholders
-11,192
-12,859
-14,781
-1,645
-3,280
Basic EPS
-
-2.88
-3.36
-0.42
-1.50
Diluted EPS
-
-2.88
-3.36
-0.42
-1.50
Basic average shares
-
4,447
4,405
3,882
2,157
Diluted average shares
-
4,447
4,405
3,882
2,157
EBITDA
-
-12,410
-14,318
-1,422
-3,220